Dihydroartemisinin News and Research

RSS
Dihydroartemisinin is a drug used to treat malaria. Dihydroartemisinin is the active metabolite of all artemisinin compounds (artemisinin, artesunate, artemether, etc.) and is also available as a drug in itself.
LSTM researchers show potential of novel antiparasitic drug to combat malaria

LSTM researchers show potential of novel antiparasitic drug to combat malaria

“Super malaria” resistant to standard medications in South East Asia

“Super malaria” resistant to standard medications in South East Asia

Study compares different strategies to prevent malaria among pregnant women in sub Saharan Africa

Study compares different strategies to prevent malaria among pregnant women in sub Saharan Africa

Study assesses acceptability of alternative drug to prevent malaria among pregnant women in Kenya

Study assesses acceptability of alternative drug to prevent malaria among pregnant women in Kenya

Dihydroartemisinin-piperaquine effective in treating malaria in pregnant women

Dihydroartemisinin-piperaquine effective in treating malaria in pregnant women

New drug may prevent malaria in pregnant women

New drug may prevent malaria in pregnant women

Pharmaceuticals against malaria can now be produced from waste of plant-extraction

Pharmaceuticals against malaria can now be produced from waste of plant-extraction

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Scientists develop novel, rapid way to test artemisinin-resistant malaria

Scientists develop novel, rapid way to test artemisinin-resistant malaria

Malaria Box helps identify three chemical series that target treatment of NTDs

Malaria Box helps identify three chemical series that target treatment of NTDs

Link between changes in malaria parasite and absorption of pharmaceutical compounds

Link between changes in malaria parasite and absorption of pharmaceutical compounds

WHO issues new guidelines for malaria treatment

WHO issues new guidelines for malaria treatment

Antimalarial drug resistance endangers malarial control measures

Antimalarial drug resistance endangers malarial control measures

Artemisinin-based combination therapy for treating uncomplicated malaria

Artemisinin-based combination therapy for treating uncomplicated malaria

NEJM Letters respond to recent studies on malaria vaccines, treatments

NEJM Letters respond to recent studies on malaria vaccines, treatments

Combo malaria treatment dihydroartemisinin and piperaquine shows promise

Combo malaria treatment dihydroartemisinin and piperaquine shows promise